Delhi outlines a comprehensive flood safety plan for the 2026 monsoon, detailing desilting, embankment upgrades, Yamuna ...

ISLAMABAD: After a gap of more than six months, the Higher Education Commission (HEC) finally has a chairman, as Prof Dr Niaz Ahmad Akhtar (Sitara-i-Imtiaz) assumed office on Friday with what he ...

TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC Paris-Dow Jones 2025 Global ...

NEW YORK, February 05, 2026--(BUSINESS WIRE)--TJC LP ("TJC" or "the Firm"), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ...

Melinda Laituri does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Francisco Partners Ranks in Top Three of the HEC Paris-Dow Jones Annual Global Large Buyout Performance Ranking for Sixth Consecutive Year #2 ranking reflects consistent strong performance over the ...

HONG KONG, Jan 28 (Reuters) - Ras Al Khaimah, one of seven city-states in the United Arab Emirates, is stepping up efforts to lure Chinese and Hong Kong investors into its real estate, green and ...

Most companies want to scale efficiently, but few truly understand the mechanics of how work gets done. That’s where business process mapping comes in. Business process mapping visually outlines how ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

If the AquaNor conference in Trondheim feels busier this year, we might have land-based aquaculture to thank. Investment in the industry exceeded $1.3 billion during the first half of 2025 and could ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.